Kanagawa, Japan

Fumiyasu Ishikawa

This inventor holds 2 USPTO granted patents. Top assignee: Kibun Company Limited. Active years: 1988-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumiyasu Ishikawa. Retrieved from https://idiyas.com/inventor/fumiyasu-ishikawa-cnoq37rj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fumiyasu Ishikawa: Innovator in Antimicrobial Peptides

Introduction

Fumiyasu Ishikawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of antimicrobial peptides, holding 2 patents that showcase his innovative work. His research focuses on the production of GIF-2, an important antimicrobial substance.

Latest Patents

Ishikawa's latest patents include a process for producing GIF-2, an antimicrobial peptide. This process involves culturing Bacillus cereus, specifically the strain FERM BP-746, under conditions that are sufficient to produce GIF-2. The peptide is then recovered from the culture medium, highlighting a novel approach to antimicrobial production.

Career Highlights

Fumiyasu Ishikawa is associated with Kibun Company Limited, where he applies his expertise in microbiology and peptide production. His work has contributed to advancements in antimicrobial research, which is crucial for developing new treatments against bacterial infections.

Collaborations

Ishikawa has collaborated with notable colleagues such as Sachio Wakayama and Kunio Oishi. These partnerships have fostered a collaborative environment that enhances the research and development of innovative antimicrobial solutions.

Conclusion

Fumiyasu Ishikawa's contributions to the field of antimicrobial peptides through his patents and collaborations underscore his role as a significant inventor. His work continues to impact the scientific community and the development of new antimicrobial therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…